Live Biotherapeutic Products (LBPs), a class of medicinal products containing live microorganisms, are reshaping treatment strategies across gastrointestinal, metabolic, immunological, and neurological conditions. Due to their biological complexity and strict regulatory classification, manufacturing these therapies demands highly specialized LBP CDMO companies with deep microbiological and GMP expertise.
Partnering with a CDMO that offers robust live biotherapeutic products contract manufacturing capabilities ensures the viability, purity, and stability of your microbial therapeutic — from early-stage development through commercial production.